Advertisement
Screener

REVVITY, INC (RVTY) Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Period Increase (Decrease)

2.8 / 5 stars · 68/120 Roast Me

REVVITY, INC Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Period Increase (Decrease)

REVVITY, INC (RVTY) reported Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Period Increase (Decrease) of $1.63 million for the 3-month period ending 2026-07-05, per its 10-Q filed 2026-08-11.

Financial Statements › Notes › Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation

us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease · last filed 2026-08-11

  • REVVITY, INC fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, period increase (decrease) for the quarter ending 2026-07-05 was $1.63M, a 254.03% increase year-over-year.
  • REVVITY, INC fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, period increase (decrease) for the quarter ending 2026-04-05 was -$99.00K.
  • REVVITY, INC fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, period increase (decrease) for the quarter ending 2025-12-28 was -$1.34M.
  • REVVITY, INC fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, period increase (decrease) for the quarter ending 2025-09-28 was $107.00K.
  • REVVITY, INC fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, period increase (decrease) for fiscal 2025 was -$1.40M.
  • REVVITY, INC fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, period increase (decrease) for fiscal 2024 was -$1.87M, a 159.75% decline from fiscal 2023.
  • REVVITY, INC fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, period increase (decrease) for fiscal 2023 was $3.13M.
  • REVVITY, INC fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, period increase (decrease) for fiscal 2023 was -$1.38M, a 144.15% decline from fiscal 2022.
Period endFair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Period Increase (Decrease) 3 monthFair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Period Increase (Decrease) 3 month as first filedFair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Period Increase (Decrease) 6 monthFair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Period Increase (Decrease) 6 month as first filedFair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Period Increase (Decrease) 9 monthFair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Period Increase (Decrease) 12 monthFair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Period Increase (Decrease) 12 month as first filed
2026-07-05$1.63M
10-Q · filed 2026-08-11
$1.53M
10-Q · filed 2026-08-11
$185.00K
derived: sum of 3 quarters · filed 2026-08-11
$292.00K
derived: sum of 4 quarters · filed 2026-08-11
2026-04-05-$99.00K
10-Q · filed 2026-05-12
-$1.44M
derived: sum of 2 quarters · filed 2026-05-12
-$1.33M
derived: sum of 3 quarters · filed 2026-05-12
-$874.00K
derived: sum of 4 quarters · filed 2026-08-11
2025-12-28-$1.34M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24
-$1.23M
derived: sum of 2 quarters · filed 2026-02-24
-$775.00K
derived: sum of 3 quarters · filed 2026-08-11
-$1.40M
10-K · filed 2026-02-24
2025-09-28$107.00K
10-Q · filed 2025-11-04
$566.00K
derived: sum of 2 quarters · filed 2026-08-11
-$59.00K
10-Q · filed 2025-11-04
-$7.93M
derived: sum of 4 quarters · filed 2026-08-11
2025-06-29$459.00K
10-Q · filed 2026-08-11
-$166.00K
10-Q · filed 2026-08-11
-$8.04M
derived: sum of 3 quarters · filed 2026-08-11
-$8.38M
derived: sum of 4 quarters · filed 2026-08-11
2025-03-30-$625.00K
10-Q · filed 2026-05-12
-$8.50M
derived: sum of 2 quarters · filed 2026-05-12
-$8.84M
derived: sum of 3 quarters · filed 2026-05-12
-$8.67M
derived: sum of 4 quarters · filed 2026-05-12
2024-12-29-$7.87M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24
-$8.22M
derived: sum of 2 quarters · filed 2026-02-24
-$8.04M
derived: sum of 3 quarters · filed 2026-02-24
-$1.87M
10-K · filed 2026-02-24
2024-09-29-$344.00K
10-Q · filed 2025-11-04
-$168.00K
derived: sum of 2 quarters · filed 2025-11-04
$6.00M
10-Q · filed 2025-11-04
$7.42M
derived: sum of 4 quarters · filed 2026-02-24
2024-06-30$176.00K
10-Q · filed 2025-08-05
$6.35M
10-Q · filed 2025-08-05
$7.76M
derived: sum of 3 quarters · filed 2026-02-24
$8.39M
derived: sum of 4 quarters · filed 2026-02-24
2024-03-31$6.17M
10-Q · filed 2025-05-06
$7.58M
derived: sum of 2 quarters · filed 2026-02-24
$8.22M
derived: sum of 3 quarters · filed 2026-02-24
$10.66M
derived: sum of 4 quarters · filed 2026-02-24
2023-12-31$1.41M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24
$2.04M
derived: sum of 2 quarters · filed 2026-02-24
$4.49M
derived: sum of 3 quarters · filed 2026-02-24
$3.13M
10-K · filed 2026-02-24
2023-10-01$633.00K
10-Q · filed 2024-11-06
$3.08M
derived: sum of 2 quarters · filed 2024-11-06
$1.72M
10-Q · filed 2024-11-06
$1.11M
derived: sum of 4 quarters · filed 2025-02-25
2023-07-02$2.44M
10-Q · filed 2024-08-06
$1.08M
10-Q · filed 2024-08-06
$478.00K
derived: sum of 3 quarters · filed 2025-02-25
-$1.65M
derived: sum of 4 quarters · filed 2025-02-25
2023-04-02-$1.36M
10-Q · filed 2024-05-07
-$1.97M
derived: sum of 2 quarters · filed 2025-02-25
-$4.10M
derived: sum of 3 quarters · filed 2025-02-25
-$3.43M
derived: sum of 4 quarters · filed 2025-02-25
2023-01-01-$607.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25
-$2.74M
derived: sum of 2 quarters · filed 2025-02-25
-$2.07M
derived: sum of 3 quarters · filed 2025-02-25
-$1.38M
10-K · filed 2025-02-25
2022-10-02-$2.13M
10-Q · filed 2023-11-07
-$1.46M
derived: sum of 2 quarters · filed 2023-11-07
-$770.00K
10-Q · filed 2023-11-07
$797.00K
derived: sum of 4 quarters · filed 2024-02-27
2022-07-03$669.00K
10-Q · filed 2023-08-09
$1.36M
10-Q · filed 2023-08-09
$2.93M
derived: sum of 3 quarters · filed 2024-02-27
$4.00M
derived: sum of 4 quarters · filed 2024-02-27
2022-04-03$693.00K
10-Q · filed 2023-05-12
$2.26M
derived: sum of 2 quarters · filed 2024-02-27
$3.33M
derived: sum of 3 quarters · filed 2024-02-27
$3.57M
derived: sum of 4 quarters · filed 2024-02-27
2022-01-02$1.57M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27
$2.64M
derived: sum of 2 quarters · filed 2024-02-27
$2.88M
derived: sum of 3 quarters · filed 2024-02-27
$3.12M
10-K · filed 2024-02-27
2021-10-03$1.07M
10-Q · filed 2022-11-14
$1.31M
derived: sum of 2 quarters · filed 2022-11-14
$1.55M
10-Q · filed 2022-11-14
$1.53M
derived: sum of 4 quarters · filed 2023-03-01
2021-07-04$237.00K
10-Q · filed 2022-08-09
$477.00K
10-Q · filed 2022-08-09
$457.00K
derived: sum of 3 quarters · filed 2023-03-01
$3.10M
derived: sum of 4 quarters · filed 2023-03-01
2021-04-04$240.00K
10-Q · filed 2022-05-10
$220.00K
derived: sum of 2 quarters · filed 2023-03-01
$2.86M
derived: sum of 3 quarters · filed 2023-03-01
$3.74M
derived: sum of 4 quarters · filed 2023-03-01
2021-01-03-$20.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01
$2.62M
derived: sum of 2 quarters · filed 2023-03-01
$3.50M
derived: sum of 3 quarters · filed 2023-03-01
-$8.83M
10-K · filed 2023-03-01
2020-10-04$2.64M
10-Q · filed 2021-11-09
$3.52M
derived: sum of 2 quarters · filed 2021-11-09
-$8.81M
10-Q · filed 2021-11-09
-$9.32M
derived: sum of 4 quarters · filed 2022-03-03
2020-07-05$879.00K
10-Q · filed 2021-08-10
-$11.45M
10-Q · filed 2021-08-10
-$11.96M
derived: sum of 3 quarters · filed 2022-03-03
-$10.73M
derived: sum of 4 quarters · filed 2022-03-03
2020-04-05-$12.32M
10-Q · filed 2021-05-11
-$12.84M
derived: sum of 2 quarters · filed 2022-03-03
-$11.61M
derived: sum of 3 quarters · filed 2022-03-03
-$11.55M
derived: sum of 4 quarters · filed 2022-03-03
2019-12-29-$518.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-03
$720.00K
derived: sum of 2 quarters · filed 2022-03-03
$779.00K
derived: sum of 3 quarters · filed 2022-03-03
$3.88M
10-K · filed 2022-03-03
2019-09-29$1.24M
10-Q · filed 2020-11-10
$1.30M
derived: sum of 2 quarters · filed 2020-11-10
$4.40M
10-Q · filed 2020-11-10
$8.23M
derived: sum of 4 quarters · filed 2021-03-02
2019-06-30$59.00K
10-Q · filed 2020-08-11
$3.16M
10-Q · filed 2020-08-11
$7.00M
derived: sum of 3 quarters · filed 2021-03-02
$10.73M
derived: sum of 4 quarters · filed 2021-03-02
2019-03-31$3.10M
10-Q · filed 2020-05-12
$6.94M
derived: sum of 2 quarters · filed 2021-03-02
$10.68M
derived: sum of 3 quarters · filed 2021-03-02
$17.62M
derived: sum of 4 quarters · filed 2021-03-02
2018-12-30$3.83M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-02
$7.57M
derived: sum of 2 quarters · filed 2021-03-02
$14.52M
derived: sum of 3 quarters · filed 2021-03-02
$14.64M
10-K · filed 2021-03-02
$14.64M
10-K · filed 2019-02-26
2018-09-30$3.74M
10-Q · filed 2019-11-05
$10.69M
derived: sum of 2 quarters · filed 2019-11-05
$10.80M
10-Q · filed 2019-11-05
$11.41M
derived: sum of 4 quarters · filed 2020-02-25
2018-07-01$6.95M
10-Q · filed 2019-08-06
$7.07M
10-Q · filed 2019-08-06
$7.67M
derived: sum of 3 quarters · filed 2020-02-25
$8.32M
derived: sum of 4 quarters · filed 2020-02-25
2018-04-01$117.00K
10-Q · filed 2019-05-07
$719.00K
derived: sum of 2 quarters · filed 2020-02-25
$1.37M
derived: sum of 3 quarters · filed 2020-02-25
$1.47M
derived: sum of 4 quarters · filed 2020-02-25
2017-12-31$602.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25
$1.25M
derived: sum of 2 quarters · filed 2020-02-25
$1.35M
derived: sum of 3 quarters · filed 2020-02-25
$2.16M
10-K · filed 2020-02-25
$2.16M
10-K · filed 2018-02-27
2017-10-01$651.00K
10-Q · filed 2018-11-06
$749.00K
derived: sum of 2 quarters · filed 2018-11-06
$1.56M
10-Q · filed 2018-11-06
$8.06M
derived: sum of 4 quarters · filed 2019-02-26
2017-07-02$98.00K
10-Q · filed 2018-08-07
$909.00K
10-Q · filed 2018-08-07
$7.41M
derived: sum of 3 quarters · filed 2019-02-26
$11.46M
derived: sum of 4 quarters · filed 2019-02-26
2017-04-02$811.00K
10-Q · filed 2018-05-08
$7.32M
derived: sum of 2 quarters · filed 2019-02-26
$11.37M
derived: sum of 3 quarters · filed 2019-02-26
$15.67M
derived: sum of 4 quarters · filed 2019-02-26
2017-01-01$6.50M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-26
$10.56M
derived: sum of 2 quarters · filed 2019-02-26
$14.86M
derived: sum of 3 quarters · filed 2019-02-26
$16.18M
10-K · filed 2019-02-26
2016-10-02$4.05M
10-Q · filed 2017-11-07
$8.36M
derived: sum of 2 quarters · filed 2017-11-07
$9.68M
10-Q · filed 2017-11-07
$9.71M
derived: sum of 4 quarters · filed 2018-02-27
2016-07-03$4.30M
10-Q · filed 2017-08-08
$5.63M
10-Q · filed 2017-08-08
$5.66M
derived: sum of 3 quarters · filed 2018-02-27
$5.73M
derived: sum of 4 quarters · filed 2018-02-27
2016-04-03$1.32M
10-Q · filed 2017-05-09
$1.35M
derived: sum of 2 quarters · filed 2018-02-27
$1.42M
derived: sum of 3 quarters · filed 2018-02-27
$1.34M
derived: sum of 4 quarters · filed 2018-02-27
2016-01-03$30.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27
$100.00K
derived: sum of 2 quarters · filed 2018-02-27
$19.00K
derived: sum of 3 quarters · filed 2018-02-27
$19.00K
10-K · filed 2018-02-27
2015-10-04$70.00K
10-Q · filed 2016-11-08
-$11.00K
derived: sum of 2 quarters · filed 2016-11-08
-$11.00K
10-Q · filed 2016-11-08
-$1.20M
derived: sum of 4 quarters · filed 2017-02-28
2015-06-28-$81.00K
10-Q · filed 2016-08-09
-$81.00K
10-Q · filed 2016-08-09
-$1.27M
derived: sum of 3 quarters · filed 2017-02-28
-$1.27M
derived: sum of 4 quarters · filed 2017-02-28
2015-03-29$0.00
10-Q · filed 2016-05-10
-$1.19M
derived: sum of 2 quarters · filed 2017-02-28
-$1.19M
derived: sum of 3 quarters · filed 2017-02-28
-$2.82M
derived: sum of 4 quarters · filed 2017-02-28
2014-12-28-$1.19M
derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-28
-$1.19M
derived: sum of 2 quarters · filed 2017-02-28
-$2.82M
derived: sum of 3 quarters · filed 2017-02-28
-$2.76M
10-K · filed 2017-02-28
2014-09-28-$7.00K
10-Q · filed 2015-11-10
-$1.63M
derived: sum of 2 quarters · filed 2015-11-10
-$1.57M
10-Q · filed 2015-11-10
$533.00K
derived: sum of 4 quarters · filed 2016-03-01
2014-06-29-$1.62M
10-Q · filed 2015-08-04
-$1.57M
10-Q · filed 2015-08-04
$540.00K
derived: sum of 3 quarters · filed 2016-03-01
-$286.00K
derived: sum of 4 quarters · filed 2016-03-01
2014-03-30$55.00K
10-Q · filed 2015-05-05
$2.16M
derived: sum of 2 quarters · filed 2016-03-01
$1.34M
derived: sum of 3 quarters · filed 2016-03-01
$1.23M
derived: sum of 4 quarters · filed 2016-03-01
2013-12-29$2.11M
derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-01
$1.28M
derived: sum of 2 quarters · filed 2016-03-01
$1.17M
derived: sum of 3 quarters · filed 2016-03-01
$944.00K
10-K · filed 2016-03-01
2013-09-29-$826.00K
10-Q · filed 2014-11-04
-$938.00K
derived: sum of 2 quarters · filed 2014-11-04
-$1.16M
10-Q · filed 2014-11-04
-$1.24M
derived: sum of 4 quarters · filed 2015-02-24
2013-06-30-$112.00K
10-Q · filed 2014-08-05
-$338.00K
10-Q · filed 2014-08-05
-$411.00K
derived: sum of 3 quarters · filed 2015-02-24
-$2.75M
derived: sum of 4 quarters · filed 2015-02-24
2013-03-31-$226.00K
10-Q · filed 2014-05-06
-$299.00K
derived: sum of 2 quarters · filed 2015-02-24
-$2.64M
derived: sum of 3 quarters · filed 2015-02-24
-$2.31M
derived: sum of 4 quarters · filed 2015-02-24
2012-12-30-$73.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-24
-$2.41M
derived: sum of 2 quarters · filed 2015-02-24
-$2.09M
derived: sum of 3 quarters · filed 2015-02-24
-$1.75M
10-K · filed 2015-02-24
2012-09-30-$2.34M
10-Q · filed 2013-11-05
-$2.01M
derived: sum of 2 quarters · filed 2013-11-05
-$1.68M
10-Q · filed 2013-11-05
-$2.42M
derived: sum of 4 quarters · filed 2014-02-25
2012-07-01$325.00K
10-Q · filed 2013-08-06
$663.00K
10-Q · filed 2013-08-06
-$78.00K
derived: sum of 3 quarters · filed 2014-02-25
$52.00K
derived: sum of 4 quarters · filed 2014-02-25
2012-04-01$338.00K
10-Q · filed 2013-05-06
-$403.00K
derived: sum of 2 quarters · filed 2014-02-25
-$273.00K
derived: sum of 3 quarters · filed 2014-02-25
$391.00K
derived: sum of 4 quarters · filed 2014-02-25
2012-01-01-$741.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-25
-$611.00K
derived: sum of 2 quarters · filed 2014-02-25
$53.00K
derived: sum of 3 quarters · filed 2014-02-25
$344.00K
10-K · filed 2014-02-25
2011-10-02$130.00K
10-Q · filed 2012-11-06
$794.00K
derived: sum of 2 quarters · filed 2012-11-06
$1.08M
10-Q · filed 2012-11-06
$1.17M
derived: sum of 4 quarters · filed 2013-02-26
2011-07-03$664.00K
10-Q · filed 2012-08-07
-$664.00K
10-Q · filed 2011-08-10
$955.00K
10-Q · filed 2012-08-07
-$955.00K
10-Q · filed 2011-08-10
$1.03M
derived: sum of 3 quarters · filed 2013-02-26
$973.00K
derived: sum of 4 quarters · filed 2013-02-26
2011-04-03$291.00K
10-Q · filed 2012-05-08
$371.00K
derived: sum of 2 quarters · filed 2013-02-26
$309.00K
derived: sum of 3 quarters · filed 2013-02-26
$411.00K
derived: sum of 4 quarters · filed 2013-02-26
2011-01-02$80.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-26
$18.00K
derived: sum of 2 quarters · filed 2013-02-26
$120.00K
derived: sum of 3 quarters · filed 2013-02-26
$197.00K
10-K · filed 2013-02-26
2010-10-03-$62.00K
10-Q · filed 2011-11-04
$40.00K
derived: sum of 2 quarters · filed 2011-11-04
$117.00K
10-Q · filed 2011-11-04
2010-07-04$102.00K
10-Q · filed 2011-08-10
-$179.00K
10-Q · filed 2011-08-10
2010-01-03-$186.00K
10-K · filed 2012-02-28

Similar stocks

Stock NameCountryMarket CapPE Ratio
Avantor, Inc. (AVTR)United States$10.501B-9.72
BRUKER CORP (BRKR)United States$9.706B-128.75
METTLER TOLEDO INTERNATIONAL INC/ (MTD)$30.436B30.62
Alamar Biosciences, Inc. (ALMR)United States$2.300B
Cytek Biosciences, Inc. (CTKB)United States$0.744B-7.15
PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB)United States$0.491B-3.95
908 Devices Inc. (MASS)United States$0.476B-9.53
EyePoint, Inc. (EYPT)United States$0.314B-3.96
Quanterix Corp (QTRX)United States$0.150B-1.65
Nautilus Biotechnology, Inc. (NAUT)United States$0.129B-4.16